Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide11Abbreviations: MRP1, multidrug resistance-associated protein 1; As2O3, arsenic trioxide; MTT, 3-(4-5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; and BSO, buthionine sulfoximine.
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (11) , 1387-1391
- https://doi.org/10.1016/s0006-2952(01)00606-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xLBlood, 2000
- Structural, mechanistic and clinical aspects of MRP1Biochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitroFEBS Letters, 1999
- Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable ConcentrationsJNCI Journal of the National Cancer Institute, 1999
- Overexpression of the multidrug resistance‐associated protein (MRP1) in human heavy metal‐selected tumor cellsFEBS Letters, 1999
- Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metalsToxicology, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonistCanadian Journal of Physiology and Pharmacology, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976